|
|
|
|
| LEADER |
02877nam a22003255i 4500 |
| 001 |
000294599 |
| 005 |
20220609142727.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100701s2009 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781603275477
|
| 024 |
7 |
|
|a 10.1007/978-1-60327-547-7
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a siRNA and miRNA Gene Silencing :
|b From Bench to Bedside /
|c edited by Mouldy Sioud.
|
| 250 |
|
|
|a 1st ed. 2009.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2009.
|
| 300 |
|
|
|a XIV, 472 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology,
|v 487
|
| 505 |
0 |
|
|a Methods for Selecting Effective siRNA Sequences by using Statistical and Clustering Techniques -- Deciphering the Code of Innate Immunity Recognition of siRNAs -- Targeted Delivery of Antisense Oligonucleotides and siRNAs into Mammalian Cells -- Local and Systemic Delivery of siRNAs for Oligonucleotides Therapy -- Imaging of siRNA Delivery and Silencing -- Recent Advances in Magnetofection and Its Potential to Deliver siRNAs In Vitro -- In Vitro and In Vivo Gene Silencing by TransKingdom RNAi (tkRNAi) -- Bacterial Delivery of siRNAs: A New Approach to Solid Tumor Therapy -- The Therapeutic Potential of LNA-modified siRNAs: Reduction of Off-target Effects by Chemical Modification of the siRNA Sequence -- pSM155 and pSM30 Vectors for miRNA and shRNA Expression -- Targeting Oncogenes with siRNAs -- Targeting Stromal-cancer Cell Interactions with siRNAs -- Therapeutic Potential of siRNA-mediated Targeting of Urokinase Plasminogen Activator, Its Receptor, and Matrix Metalloproteinases -- Silencing of HIF-1#x03B1; by RNA Interference in Human Glioma Cells In Vitro and In Vivo -- RNA Interference-Mediated Validation of Genes Involved in Telomere Maintenance and Evasion of Apoptosis as Cancer Therapeutic Targets -- Treating Respiratory Viral Diseases with Chemically Modified, Second Generation Intranasal siRNAs -- Progress in the Therapeutic Applications of siRNAs Against HIV-1 -- Protein Components of the microRNA Pathway and Human Diseases -- Intron-Mediated RNA Interference and microRNA Biogenesis -- Emergence of a Complex Relationship between HIV-1 and the microRNA Pathway -- Synthetic microRNA Targeting Glioma-associated Antigen-1 Protein -- Therapeutic Targeting of Gene Expression by siRNAs Directed Against BCR-ABL Transcripts in a Patient with Imatinib-Resistant Chronic Myeloid Leukemia.
|
| 650 |
|
0 |
|a Biochemistry.
|
| 650 |
|
0 |
|a Human genetics.
|
| 650 |
|
0 |
|a Gene expression.
|
| 650 |
1 |
4 |
|a Biochemistry, general.
|
| 650 |
2 |
4 |
|a Human Genetics.
|
| 650 |
2 |
4 |
|a Gene Expression.
|
| 700 |
1 |
|
|a Sioud, Mouldy.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|